#Analyst Ratings

2 articles tagged with this topic

โ—‰ ViewAdvancedIndustry Deep Dives โ€บ Company & Industry Analysis

CVS Health: Why Stability is the New Growth Strategy

Following recent management discussions, UBS has reiterated its Buy rating on CVS Health. We explore why the market is finding comfort in the company's lack of negative surprises.

1mยท๐Ÿ‘ 0
โ—‰ ViewAdvancedIndustry Deep Dives โ€บ Company & Industry Analysis

Canaccord Genuity Revises Price Outlook for Generac Holdings

Canaccord Genuity has adjusted its price target for power equipment manufacturer Generac Holdings. The move reflects shifting analyst sentiment regarding the company's long-term growth potential in the energy resilience sector.

2mยท๐Ÿ‘ 0